Anti-IL-12 antibodies, epitopes, compositions, methods and uses
JP2014195458A
Anti-il-6 antibody, composition, method and use
AU2012258409A1
Anti-IL-23 antibodies, compositions, methods and uses
AU2012241182A1
Toll like receptor 3 antagonists, methods and uses
AU2012203565A1
Anti-IL-12 antibodies, epitopes, compositions, methods and uses
JP2012055312A
Anti-il-6 antibody, composition, method and use
AU2011202563A1
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
US2011195063A1
Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor
JP2010148512A
Anti-il-6 antibody, composition, method and use thereof
US2009176238A1
Cynomolgus toll-like receptor 3
WO2009079446A1
Method and system for distributing information between patients, health care providers, caregivers, and payors
AU2008343591A1
Engineered hybird phage vectors for the design and the generation of a human non-antibody peptide or protein phage library via fusion to pIX of M13 phage
CN101918027A
Semi-synthetic GLP-1 peptide-Fc fusion constructs, methods and uses
WO2009058957A2
Intranasal administration of active agents to the central nervous system
WO2009045894A1
Methods and structural conformations of antibody preparations with increased resistance to proteases
CN101889021A
Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
WO2009009782A2
Cynomolgus il-17 proteins, antibodies, compositions, methods and uses
WO2009003096A2
Il-17 mutein proteins, antibodies, compositions, methods and uses
WO2008147938A2
Wnt5a as an inflammatory disease marker
WO2008141274A1
Anti-alpha v immunoliposome composition, methods and uses
